Allspring Global Investments
CSTL icon

Allspring Global Investments’s Castle Biosciences CSTL Stock Holding History

Allspring Global Investments’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98M Buy
292,470
+131,807
+82% +$2.94M 0.01% 823
2026
Q1 		$3.94M Buy
160,663
+1,492
+0.9% +$48.9K 0.01% 910
2025
Q4 		$6.13M Buy
159,171
+2,658
+2% +$85.7K 0.01% 817
2025
Q3 		$3.56M Sell
156,513
-4,662
-3% -$94.7K 0.01% 930
2025
Q2 		$3.29M Sell
161,175
-56,619
-26% -$1.05M 0.01% 961
2025
Q1 		$4.36M Buy
217,794
+207,761
+2,071% +$5.14M 0.01% 956
2024
Q4 		$267K Buy
10,033
+23
+0.2% +$700 ﹤0.01% 1613
2024
Q3 		$285K Sell
10,010
-741
-7% -$18.9K ﹤0.01% 1612
2024
Q2 		$234K Sell
10,751
-111
-1% -$2.47K ﹤0.01% 1676
2024
Q1 		$241K Buy
10,862
+5,123
+89% +$111K ﹤0.01% 1670
2023
Q4 		$124K Buy
5,739
+5,189
+943% +$91.3K ﹤0.01% 1772
2023
Q3 		$9.29K Sell
550
-377,837
-100% -$6.61M ﹤0.01% 2613
2023
Q2 		$5.19M Buy
378,387
+9,934
+3% +$201K 0.01% 985
2023
Q1 		$8.37M Buy
368,453
+15,623
+4% +$382K 0.01% 837
2022
Q4 		$8.31M Buy
352,830
+588
+0.2% +$13.6K 0.01% 834
2022
Q3 		$9.19M Sell
352,242
-116,600
-25% -$3.27M 0.02% 804
2022
Q2 		$10.3M Buy
468,842
+21,786
+5% +$506K 0.02% 773
2022
Q1 		$20.1M Sell
447,056
-5,672
-1% -$234K 0.03% 665
2021
Q4 		$19.4M Buy
+452,728
New +$23.7M 0.02% 715

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's CSTL Position: Q2 2026 in Review

Allspring Global Investments increased its Castle Biosciences (CSTL) stake by 82% in Q2 2026, buying an estimated $2.94M and bringing the position to 292,470 shares worth $6.98M. The position accounts for 0.01% of the portfolio, ranked #823.

Allspring Global Investments first reported a position in CSTL in Q4 2021 and has held it in 19 quarters since. The position peaked at $20.1M in Q1 2022. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Allspring Global Investments held 292,470 shares of Castle Biosciences worth $6.98M as of Q2 2026.
  • Allspring Global Investments bought 131,807 Castle Biosciences shares in Q2 2026, an estimated $2.94M.
  • Castle Biosciences made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #823 holding.
  • Allspring Global Investments first reported a position in Castle Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Castle Biosciences position peaked at $20.1M in Q1 2022.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.